ACLARION, INC. Payments of Stock Issuance Costs
ACLARION, INC. (ACON) reported Payments of Stock Issuance Costs of $698.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06
- ACLARION, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $19.28K, a 1928300.00% increase year-over-year.
- ACLARION, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $679.61K, a 65.32% decline year-over-year.
- ACLARION, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $164.65K, a 123.20% increase year-over-year.
- ACLARION, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $283.80K.
- ACLARION, INC. payments of stock issuance costs for fiscal 2025 was $2.41M, a 205.56% increase from fiscal 2024.
- ACLARION, INC. payments of stock issuance costs for fiscal 2024 was $788.10K.
- ACLARION, INC. payments of stock issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ACLARION, INC. payments of stock issuance costs for fiscal 2022 was $365.06K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 6 month as first filed | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $698.89K 10-Q · filed 2026-08-06 | $863.53K derived: sum of 3 quarters · filed 2026-08-06 | $1.15M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $679.61K 10-Q · filed 2026-05-13 | $844.25K derived: sum of 2 quarters · filed 2026-05-13 | $1.13M derived: sum of 3 quarters · filed 2026-05-13 | $1.13M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $164.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $448.44K derived: sum of 2 quarters · filed 2026-03-18 | $448.44K derived: sum of 3 quarters · filed 2026-08-06 | $2.41M 10-K · filed 2026-03-18 | ||
| 2025-09-30 | $283.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $283.80K derived: sum of 2 quarters · filed 2026-08-06 | $2.24M 10-Q · filed 2025-11-12 | $2.32M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.96M 10-Q · filed 2026-08-06 | $2.03M derived: sum of 3 quarters · filed 2026-08-06 | $1.92M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $1.96M 10-Q · filed 2026-05-13 | $2.03M derived: sum of 2 quarters · filed 2026-05-13 | $1.92M derived: sum of 3 quarters · filed 2026-05-13 | $2.03M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $73.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$40.84K derived: sum of 2 quarters · filed 2026-03-18 | $75.20K derived: sum of 3 quarters · filed 2026-03-18 | $788.10K 10-K · filed 2026-03-18 | ||
| 2024-09-30 | -$114.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.43K derived: sum of 2 quarters · filed 2025-11-12 | $714.33K 10-Q · filed 2025-11-12 | $401.74K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $116.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $828.94K 10-Q · filed 2025-08-14 | $256.09K 10-Q · filed 2024-08-14 | $516.35K derived: sum of 3 quarters · filed 2025-08-14 | $828.94K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $712.90K 10-Q · filed 2025-05-15 | $143.46K 10-Q · filed 2024-05-15 | $400.31K derived: sum of 2 quarters · filed 2025-05-15 | $712.90K derived: sum of 3 quarters · filed 2025-05-15 | $712.90K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$312.59K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $312.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $312.59K derived: sum of 2 quarters · filed 2024-08-14 | $312.59K 10-Q · filed 2023-11-14 | $312.59K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $85.00K 10-Q · filed 2023-08-25 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $365.06K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $365.06K 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $365.06K 10-Q · filed 2023-08-25 | |||||
| 2021-12-31 | $0.00 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |